AstraZeneca Estimates Rs 35 Crore Tax Benefit After ITAT Remands Transfer Pricing Issues Farhat Nasim4 Dec 2024 6:32 PM ISTNew Delhi: AstraZeneca Pharma India Limited has estimated a potential tax benefit of approximately Rs 35 crore following a favorable ruling from...
Delhi HC Upholds AstraZeneca's Tagrisso Patent, Imposes Rs 7L Fine on 'Habitual Infringer' for Knockoff Production Farhat Nasim2 Dec 2024 4:48 PM ISTNew Delhi: In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical Works Ltd....
Submit Clinical Data in Indian Subjects: CDSCO Panel Tells AstraZeneca on Trastuzumab deruxtecan Dr. Divya Colin1 Dec 2024 5:30 PM ISTNew Delhi: Responding to the proposal presented by AstraZeneca Pharma India for the approval of additional indication of the drug Trastuzumab...
Addition of AstraZeneca breast cancer drug Enhertu to China state insurance list Ruchika Sharma29 Nov 2024 5:29 PM ISTChina: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance scheme from January 1, as per...
NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details Farhat Nasim20 Nov 2024 4:08 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...
AstraZeneca Tagrisso recommended for approval in EU by CHMP for patients with unresectable EGFR mutated lung cancer Ruchika Sharma19 Nov 2024 12:15 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients...
AstraZeneca invests USD 3.5 billion in RnD, manufacturing in US Ruchika Sharma15 Nov 2024 3:08 PM ISTCambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company's research and...
AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer Ruchika Sharma14 Nov 2024 3:15 PM ISTAstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan...
CDSCO panel Approves AstraZeneca's Protocol Amendment proposal for Datopotamab Deruxtecan study Dr. Divya Colin7 Nov 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
AstraZeneca Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis Ruchika Sharma31 Oct 2024 1:45 PM ISTCambridge: AstraZeneca has announced that Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult...
Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition MD Bureau24 Oct 2024 2:09 PM IST"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
